Investing Profile

Peter Dudek

InvestorVC
President & Managing Partner, MRL Ventures Fund at Merck
mrlv.comCambridge, Massachusetts
Photo of Peter Dudek, President at MRL Ventures Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$15.0M - $20.0M
$17.5M
5
CompanyStageDateRound SizeTotal Raised
Carisma Therapeutics
Series CSep 2022$30M
Series BMar 2021$12M
$150M
Co-investors: Margarita Chavez (AbbVie Ventures), Dr. Regina Hodits (Wellington Partners), Geeta Vemuri (Agent Capital)
Mozart Therapeutics
Series AOct 2021$55M
$55M
Co-investors: Lucio Iannone (Leaps by Bayer), Henrijette Richter (Soffinova Partners), Steven Gillis (ARCH Venture Partners)
Xilio Therapeutics
Series CFeb 2021$95M
Series BMar 2020$100M
$330M
Co-investors: Mike Ross (SV Health Investors), Jayson Punwani (Abingworth), Nancy Hong (RiverVest), Andrew Hack (Bain Capital Life Sciences), Jack Kenney (SV Health Investors)